Skip to content

Comparison of different supraglottic airway devices following tracheal extubation

Comparison efficacy and safety of the SLIPA and I-gel versus laryngeal mask following tracheal extubation

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2016100514056N10
Enrollment
105
Registered
2016-10-24
Start date
2016-07-25
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Extubation. Failure to introduce or to remove other tube or instrument

Interventions

Intervention 1: In first group laryngeal mask insert inferior to a tracheal tube with empty cuff then extubation perform and ventilation continue with laryngeal mask. Intervention 2: In first group S
Prevention
In first group laryngeal mask insert inferior to a tracheal tube with empty cuff then extubation perform and ventilation continue with laryngeal mask.
In first group SLIPA insert inferior to a tracheal tube then extubation perform and ventilation continue with SLIPA.
In first group I-gel insert inferior to a tracheal tube then extubation perform and ventilation continue with I-gel .

Sponsors

Arak University of Medical Sciences, Vice Chancellor for Research
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: ASA class I and II; Age 15 to 70 years old; Duration of surgery between 120 to 180 minutes; Supine position. Exclusion criteria: Difficult airway (Mallampati class III and IV); History of Gastroesophageal Reflux Disease; History of Chronic Obstructive Pulmonary Disease; Pregnancy; Body mass index greater than 30; Facial, head and neck surgery; Surgery duration less than 120 and greater than 180 minutes.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Amount of cough. Timepoint: record until full consciousness. Method of measurement: Observation.;Amount of laryngospasm. Timepoint: record until full consciousness. Method of measurement: Observation.;Airway obstruction. Timepoint: record until full consciousness. Method of measurement: Observation.;Apnea. Timepoint: record until full consciousness. Method of measurement: Observation.;Respiration trap. Timepoint: record until full consciousness. Method of measurement: Observation.;Gag reflux. Timepoint: record until full consciousness. Method of measurement: Observation.;Vomiting. Timepoint: record until full consciousness. Method of measurement: Observation.;Need to reintubation. Timepoint: record until full consciousness. Method of measurement: Observation.

Secondary

MeasureTime frame
Arterial oxygen saturation. Timepoint: every 5 minutes after insertion of supraglottic devices until full consciousness. Method of measurement: Puse oximeter.;Blood pressure. Timepoint: every 5 minutes after insertion of supraglottic devices until full consciousness. Method of measurement: sphygmomanometer.;Pulse rate. Timepoint: every 5 minutes after insertion of supraglottic devices until full consciousness. Method of measurement: pulse rate in 1 minute.;Respiratory rate. Timepoint: every 5 minutes after insertion of supraglottic devices until full consciousness. Method of measurement: Respiratory rate in 1 minute.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Hesameddin Modir

Arak University of Medical Sciences

He_modir@yahoo.com+98 86 3417 3641

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026